Element Capital Management LLC Purchases Shares of 87,352 Lumexa Imaging Holdings, Inc. $LMRI

Element Capital Management LLC acquired a new position in shares of Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI) in the 4th quarter, HoldingsChannel reports. The fund acquired 87,352 shares of the company’s stock, valued at approximately $1,616,000. Lumexa Imaging comprises approximately 0.8% of Element Capital Management LLC’s holdings, making the stock its 29th biggest position.

A number of other hedge funds have also made changes to their positions in LMRI. Assetmark Inc. purchased a new stake in Lumexa Imaging during the fourth quarter worth approximately $36,000. Barclays PLC purchased a new position in Lumexa Imaging in the fourth quarter valued at approximately $133,000. Sandia Investment Management LP acquired a new stake in Lumexa Imaging during the fourth quarter worth approximately $185,000. Hudson Bay Capital Management LP purchased a new stake in shares of Lumexa Imaging during the 4th quarter worth approximately $237,000. Finally, Burkehill Global Management LP acquired a new position in shares of Lumexa Imaging in the 4th quarter valued at $925,000.

Lumexa Imaging Stock Performance

NASDAQ LMRI opened at $8.79 on Thursday. Lumexa Imaging Holdings, Inc. has a 52-week low of $6.45 and a 52-week high of $19.45. The business’s 50-day moving average is $8.84.

Insiders Place Their Bets

In related news, Director Brett Brodnax bought 35,000 shares of the stock in a transaction on Tuesday, May 19th. The shares were bought at an average cost of $7.25 per share, for a total transaction of $253,750.00. Following the purchase, the director owned 62,027 shares of the company’s stock, valued at $449,695.75. This trade represents a 129.50% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages recently commented on LMRI. Barclays cut their price target on shares of Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a research note on Wednesday, May 20th. Weiss Ratings raised Lumexa Imaging from a “sell (e-)” rating to a “sell (e)” rating in a report on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).